Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Agonist antibodies that bind human CD137 and uses thereof

Agonist antibodies that bind human CD137 and uses thereof

US Patent 11752207 · Granted Sep 12, 2023

Estimated economic value: $4,714,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multispecific binding constructs against checkpoint molecules and uses thereof2025
Multispecific binding constructs against checkpoint molecules and uses thereof2025
Antigen binding molecules targeting SARS-CoV-22025
Transgenic mouse expressing common human light chain2025
Antibodies that bind CD277 and uses thereof2025
Antibodies that bind CD277 and uses thereof2025
Antibodies that bind CD277 and uses thereof2025
Fusion polypeptides comprising interleukin 12 and a metal-hydroxide binding poly2025
Variable lymphocyte receptors that target the blood brain barrier and methods of2025
Method of treating cancer using CD137 antibodies and PD-1 antagonists2025
Method of treating cancer using CD137 antibodies and PD-1 antagonists2025
Tumor-specific cleavable linkers2025